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Abstract: Ginseng is a traditional herbal adaptogen that has been historically used in China and 
the Far East. Ginsenosides are the active component of ginseng known to exert several actions by 
targeting “multi-receptor systems”, both extracellular and intracellular. In humans, ginseng effects 
remain unclear. This study aimed to investigate whether ginseng can influence salivary androgen 
levels (testosterone and dehydroepiandrosterone (DHEA)) in females. The study followed a 
parallel partially controlled design. Healthy women (n = 24) were recruited and divided into two 
groups (A = 20–32 and B = 38–50 years). Volunteers were asked to maintain a food diary pre and 
post ginseng consumption and collected four salivary samples (7 a.m., 9 a.m., 12 p.m., and 5 p.m.) 
before and after ingesting 75 mg red Korean ginseng extract per day for seven days. Testosterone 
and DHEA were then assayed by ELISA methods. Group A’s mean daily salivary testosterone pre 
ginseng ingestion increased from 76.3 ± 16.6 to 98.4 ± 21.1 pg/mL post ginseng (p < 0.01) with 
significant difference at all time points, and mean daily salivary DHEA increased from 1.53 ± 0.63 
to 1.98 ± 0.89 ng/mL post ginseng (p = 0.02). Group B’s mean daily salivary testosterone pre 
ginseng ingestion was 61.2 ± 16.9 and post ginseng 68.1 ± 11.5 pg/mL (p = 0.132), and daily salivary 
DHEA increased from 0.91 ± 0.32 to 1.62 ± 0.49 ng/mL post ginseng (p = 0.014) with significant 
difference at all time points. In conclusion, it appears that ginseng intake significantly increased 
salivary testosterone levels in the younger women group, but only slightly in the older group. 
However, DHEA levels in the older women showed a marked and significant increase. These 
results suggest a potential role for ginseng in modulating salivary androgen levels and that such 
effect may be more evident in older women where the levels of androgens (DHEA) start to 
decline. However, it has to be stressed that our results are preliminary and further properly 
controlled trials are justified. 
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1. Introduction 
Panax ginseng or Korean ginseng (Araliaceae) has been used as herbal medicine for more than 
2000 years [1], and utilized as an adaptogenic agent to enhance resistance to stress and aging and 
improve physical performance [2–4]. Ginseng has numerous pharmacological effects on the 
reproductive, cardiovascular, endocrine, and immune systems. It has the ability to reduce fatigue, 
improve blood circulation, relieve menopausal symptoms, boost immune function, and influence 
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steroid hormone levels [5–7]. Shibata et al. [8] isolated and identified the structures of ginseng 
saponins from the plant roots in 1963. Ginsenosides are steroidal saponins that have the four trans-
ring rigid steroid skeleton with a variety of sugar moieties (see Figure 1) [4,9,10] and they represent 
the active constituents of panax ginseng. Ginsengs contain approximately 200 substances, such as 
ginsenosides, polysaccharides, polyacetylenes, peptides, amino acids, polyacetylenic alcohols, and 
fatty acids [1,4,8]. Currently, there are more than 26 isolated ginsenosides [11] that differ primarily 
in the number and position of sugar conjugates [9–11]. Ginsenoside Rh2, Rh1, F1, Rb1, and Rb2 and 
protopanaxatriol ginsenoside Rg1 are the most abundant types [1,4]. Ginsenosides activate the 
genomic pathway by binding the intracellular nuclear hormone receptors such as the glucocorticoid 
receptor, progesterone receptor, androgen receptor, mineralocorticoid receptor, estrogen receptor, 
peroxisome proliferator-activated receptor, and liver X receptor [12–21]. Ginsenosides and steroid 
hormones have similar structural characteristics; both are lipid-soluble signaling molecules that 
initiate a cellular response [8,9]. Ginsenoside Rb1 can bind and activate the estrogen receptor and 
other steroid receptors, including those of testosterone and other steroids [9]. 
Dehydroepiandrosterone (DHEA) and its sulphated ester, Dehydroepiandrosterone sulphate 
DHEAS are the precursors of testosterone produced primarily by the adrenal cortex, and are 
secretary products of the adrenal zona reticularis [22]. DHEA can be derived from circulating 
DHEAS catalyzed by steroid sulphatase [23]. DHEA and DHEAS are pro-androgens [22,24] and are 
precursors for other androgens and estrogens including testosterone and estradiol plus several 
other actions in the body. Other actions reported include the use of ginseng for the treatment of 
osteoporosis [25], inhibition of platelet aggregation [26], prevention of Alzheimer’s disease through 
the protection against beta-amyloid peptide-induced neuronal apoptosis [13,27], anti-oxidative 
stress effect of red ginseng in brain [18], inhibition of apoptosis in neuroblastoma cells and human 
breast cancer [28,29], and protection against testicular damage and gene expression in rats [30]. In 
women, 75% of premenopausal estrogens [31] and 100% of postmenopausal estrogens originate 
from DHEA [32]. It is now known that the levels of both DHEA and DHEAS in serum decline with 
age, and thus DHEA supplementation could improve ovarian function, increase pregnancy 
chances, and lower miscarriage rates in women [32,33].  
Testosterone is produced in the testes of males and ovaries of females. However, testosterone 
can also be synthesized peripherally from DHEA by intracellular conversion. Transformation of 
DHEA and DHEAS depends on the expression of various steroidogenic enzymes [24]. Salivary 
testosterone represents the concentration of bio-available testosterone. Even though DHEAS 
exceeds the concentration of DHEA by approximately 300–500 times [34], the salivary DHEA 
represents bioavailable DHEA and not DHEAS. The unconjugated DHEA enters saliva by 
intracellular diffusion and represents the concentration of unbound active DHEA in plasma [35]. 
The aim of this study was to determine if ginseng intake could influence salivary testosterone and 
DHEA in healthy females. The ginsenoside content varies considerably in over-the-counter 
products. This study used Korean ginseng prepared from the dried roots of the species Panax C.A. 
Meyer (Red Kooga Korean Ginseng) which contains not less than 10% of ginsenosides. 
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Figure 1. Chemical structure of the ginsenoside Rg1, a member of the dammarane family of 
molecules. Ginsenosides or panaxosides are a class of natural steroid glycosides and triterpene 
saponins found almost exclusively in the plant genus Panax (ginseng) [9]. 
2. Materials and Methods 
2.1. Materials 
Korean red ginseng manufactured by Red Kooga was purchased from Superdrug, Edinburgh, 
UK. Each capsule contained 75 mg of ginseng extract (equivalent to 600 mg ginseng root powder) 
with a guaranteed ginsenoside content of 7.5 mg. Diethyl ether and methanol were obtained from 
Fisher Scientific, Loughborough, UK. Sheep anti-DHEA antibody (used at a final dilution of 
1:40,000), anti-testosterone antibody (used at a final dilution of 1:200,000), and horseradish 
peroxidase-donkey sheep anti-sheep conjugate (used at a concentration of 1: 10,000) were 
purchased from Micropharm Ltd., Newcastle Emlyn, UK. Testosterone and DHEA standards, 
Tween 20, sulfuric acid, tetra-methyl-benzidine, bovine serum albumin were purchased from 
Sigma-Aldrich, Poole, UK. ELISA plates were obtained from Griener Bio-One, Frickenhausen, 
Germany.  
2.2. Study Design 
The study followed a modified parallel and partially controlled placebo design where the 
participants chose to take the ginseng capsules and some then volunteered to take the placebo 
(maltodextrin) similar to the ginseng capsules. Information sheets were provided to all potential 
volunteers and written informed consent from each participant was obtained prior to participation. 
The study was granted ethical approval by the Divisional Ethics Committee at Queen Margaret 
University, Edinburgh, United Kingdom, code: 02022630/2012-HONORS/ GINSENG/DNBS/QMU 
Ethical Committee. The intervention was conducted according to the guidelines laid down in the 
Declaration of Helsinki [36]. All collected data were stored according to the Data Protection Act 
(1998) [37]. 
2.3. Subject Recruitment 
Participants were recruited from the local community (including students and staff) through 
advertising in the Queen Margaret University research recruitment digest and by word-of-mouth. 
Eligible participants included women, aged 20–50 years with a BMI between 18 and 34.9 kg/m². 
Volunteers answered the pre-assessment questionnaire before they registered for the study to 
ensure they did not have any symptomatic disease. Exclusion criteria included taking medication 
for diabetes, heart, liver, or kidney disease. Pregnant and lactating women and those with allergies 
to ginseng were also excluded. Subjects (n = 24; 12 were Queen Margaret students and 12 were 
Queen Margaret staff) were stratified according to age into 2 groups: Group A was composed of 12 
subjects aged 20–32 years and Group B was composed of another 12 subjects aged 38–50 years.  
2.4. Ginseng Supplement 
Red Kooga Korean red ginseng was used and standardized so that each capsule contained 75 
mg ginseng extract (equivalent to 600 mg ginseng root powder) with a guaranteed ginsenoside 
content of 7.5 mg [6]. Chemical analysis of a ginseng capsule was not preformed, thus the 
ginsenoside content was according to the manufacturer’s label. It is known that Korean ginseng 
generally consists of the main root and the lateral or fine roots at a ratio of about 3:1. The Panax red 
ginseng used in our study was produced according to the method previously developed by Lee et 
al. [38]. The consort statement for the reporting of herbal trials was followed [39]. The ginsenoside 
content of the red ginseng used (mg/g) was as follows: Rg1 = 3.3, Re = 2.0, Rb1 = 5.8, Rc =1.7, Rb2 = 
2.3, and Rd = 0.4. Each subject consumed 1 ginseng capsule orally for seven days. However, Red 
Kooga recommends 1 capsule should be consumed orally for eight weeks.  
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2.5. Study Protocol 
Subjects collected basal saliva samples (3 mL) at 7 a.m., 9 a.m., 12 p.m., and 5 p.m. before the 
intake of ginseng and kept a food diary for 48 hours (including 1 weekday and 1 weekend day). 
Subjects then consumed one 75 mg ginseng capsule extract daily for 7 days and maintained a 
second 48-hour food diary (including 1 weekday and 1 weekend day). Saliva samples (3 mL) were 
also collected on the final day of ginseng supplementation at 7 a.m., 9 a.m., 12 p.m., and 5 p.m. All 
subjects decided to take ginseng capsules (one capsule per day) for one week, followed by the 
collection of saliva samples and the diet diaries. All subjects were first supplied with 7 ginseng 
capsules, 1 packet sugar free chewing gum, 8 labelled collection tubes and an information sheet on 
saliva sample collection. For the placebo arm, 6 subjects from each group then volunteered to take a 
placebo of maltodextrin similar to the ginseng capsules following a washout period of 1 week. They 
were then supplied with the same things as before. 
2.6. Diet Diaries 
To account for any changes in energy and macronutrient intake (carbohydrate, protein, fat, and 
total energy) that might influence the results, a two-day food diary was collected at baseline and 
over the same days of the intervention week. Subjects completed a four-day diet diary, that is, 48 
hours pre ginseng (including 1 weekday and 1 weekend day) and similarly 48 hours post ginseng. 
Nutrient intakes were generated using the Win Diets Research software program (Version 2010, 
Robert Gordon University, Aberdeen, UK). Food recording support and training, including 
guidance on portion sizes and household measures, were provided by the researcher to assist 
participants in completing the food diaries.  
2.7. Sample Preparation and Hormone Estimation 
Saliva samples were frozen immediately following collection at –20 °C. Then, they were 
thawed and centrifuged at 3600 rpm for 10 minutes to remove debris, and 3 aliquots of 700 µL in 
Eppendorf tubes were labelled and frozen at –20 °C until required. Samples containing pre and post 
ginseng saliva were defrosted and centrifuged at 2600 g for 3 minutes, and 0.5 mL of each sample 
was extracted with diethyl ether for 10 minutes [23]. The ether layer was then evaporated under 
nitrogen at 45 °C and the residue was reconstituted in 0.5 mL of assay buffer (PBS + 0.1% BSA). 
Testosterone and DHEA were then assayed by highly specific and sensitive ELISA standard 
protocols previously described by Al-Dujaili and colleagues [23,40].  
2.8. Statistical Analysis 
Data were analyzed using Microsoft Excel and SPSS for Windows version 21.0 (SPSS, Chicago, 
IL, USA) and expressed as mean ± SD or SEM. Differences in baseline characteristics were examined 
using independent t-tests. For multiple comparisons, data were analyzed using two-way mixed 
model analysis of variance (ANOVA) with time (baseline, week 1 post ginseng) as within-subject 
factor, and treatment (ginseng/placebo) as between-subject factor. Energy, protein, fat, and 
carbohydrate intakes were analyzed using paired t-tests. Significance was set at p ≤ 0.05.  
3. Results 
All volunteers recruited completed the study. Mean age (± SD) of group A was 23.2 ± 3.6 years 
and of group B was 42.8 ± 4.3 years (p < 0.001). Weight and height were estimated enabling a body 
mass index (BMI) calculation. Group A recorded a BMI value of 23.6 ± 3.2, and group B’s BMI was 
26.9 ± 4.4 (mean ± SD). An independent paired t-test was preformed determining no significant 
difference between the weight (p = 0.276) or BMI (p = 0.075) between groups A and B. This was a 
desirable result as the authors contend that the androgen levels obtained were not significantly 
influenced by weight. None of our female subjects were taking oral contraceptive (OC) medications. 
This was important as researchers have reported that OC medications decrease bio-available 
testosterone, DHEA, and DHEAS [41,42]. Alcohol intake is known to affect steroid hormone levels. 
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However, subjects agreed not to consume excessive amounts of alcohol during the study and 
alcohol consumption was prohibited 24 hours prior to saliva collection. Therefore, it was assumed 
that alcohol did not influence the results of this study. 
Table 1. Average daily salivary steroid values of groups A and B volunteers pre and post ginseng 
consumption. 
Average daily value Pre Ginseng ± SD Post Ginseng ± SD p-value 
Group A Testo (pg/mL) 76.3 16.6 98.4 21.1 < 0.01 
Group B Testo (pg/mL) 61.6 16.9 68.4 11.5 0.132 
Group A DHEA (ng/mL) 1.53 0.63 1.98 0.89 0.02 
Group B DHEA (ng/mL) 0.91 0.32 1.62 0.49 0.014 
Salivary testosterone and DHEA decrease with age as reported by many authors [43,44]. The 
mean daily salivary testosterone pre (76.3 pg/mL) and post (98.4 pg/mL) ginseng supplementation 
(p < 0.01) in individuals aged from 20 to 32 years was greater than the mean daily salivary 
testosterone pre (61.6 pg/mL) and post (68.40 pg/mL) ginseng supplementation (p = 0.132) in 
individuals aged from 38 to 50 years. Similarly, the production of DHEA and DHEAS was found to 
be reduced with age as previously reported [24,45]. The mean daily salivary DHEA pre (1.53 
ng/mL) and post (1.98 ng/mL) ginseng supplementation (p = 0.02) in individuals between 20 and 32 
years was greater than the mean daily salivary DHEA pre (0.91 ng/mL) and post (1.62 ng/ml) 
ginseng supplementation (p = 0.014) in individuals aged between 38 and 50 years (see Table 1). As 
shown in Table 1, there was a marked increase in the mean daily salivary testosterone in group A 
subjects (p < 0.01) post ginseng intake. However, in group B subjects, there was a slight increase in 
mean daily salivary testosterone but it was not significant (p = 0.132). In contrast, mean daily 
salivary DHEA increased significantly following ginseng intake in group A (p = 0.02) and group B 
(p = 0.014) volunteers.  
Steroid hormones demonstrate circadian rhythm as confirmed by several studies [43,45,46]. 
Mean salivary testosterone and DHEA levels at 7 a.m. were the highest in our study for individuals 
aged between 20 and 30 years and those aged between 38 and 50 years at baseline (Figures 2 and 3). 
The levels for both steroids post ginseng supplementation reduced up to 12 noon, and then they 
tended to fluctuate following that time. At 5 p.m., salivary testosterone showed an increase as well 
as the DHEA levels in group A subjects. However, in group B subjects, the DHEA levels continued 
to decrease (see Figures 2 and 3). It seems that the erogenic effect of ginseng on DHEA in women 
aged between 38 and 50 years was greater than that in women aged between 20 and 32 years, 
although no significant difference was observed. Salivary testosterone and DHEA samples obtained 
from subjects who performed the placebo were measured by the same ELISA methods. The placebo 
data were very similar to those obtained by groups A and B volunteers at basal and were not 
statistically different from those obtained pre ginseng consumption. Therefore, placebo data 
comparisons were performed with post ginseng values using ANOVA and they revealed that the 
results obtained were not statistically different when pre and post ginseng data were analyzed.  
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Figure 2. Daily salivary testosterone levels (mean ± SEM) for individuals aged 20–32 years (group 
A) and those aged 32–50 years (group B) pre and post ginseng supplementation. There were 
significant increases in testosterone at all time points in group A: 7 a.m., p < 0.01; 9 a.m., p = 0.0031; 
12 noon, p = 0.026, 5 p.m., p = 0.044. There was no significant increase at all times in group B. 
 
Figure 3. Daily salivary dehydroepiandrosterone (DHEA) testosterone levels for individuals aged 
20–32 years (group A) and those aged 38–50 years (group B) pre and post ginseng intake (mean ± 
SEM). There was a significant increase in DHEA at 7 a.m. only in group A (p = 0.017). It was 
determined that mean DHEA in group B increased at all time points (7 a.m., p = 0.05; 9 a.m., p = 
0.037; 12 noon, p = 0.04, 5 p.m., p = 0.046). 
Analysis of food intake was performed using SPSS to determine if there was a significant 
difference between energy, carbohydrate, fat, and protein consumed pre and post ginseng in 
groups A and B. There were no significant differences in group A’s macronutrient intake between 
pre and post ginseng supplementation (Table 2). However, the energy (p = 0.05) and fat (p = 0.041) 
intakes of group B were significantly different pre and post ginseng supplementation, presumably 






































Nutrients 2020, 12, 1582 7 of 13 
Table 2. Comparison of macronutrient intake (energy, protein, carbohydrate, and fat) of groups A 
and B volunteers pre and post ginseng supplementation. 
Nutrient Mean ± SD  Paired t-test 
Group A    
Energy (kcal) Pre 1610.46 336.701 
0.376  Post 1446.11 384.541 
Protein (g) Pre 64.44 16.704 
0.435  Post 58.22 23.419 
Carbohydrate (g) Pre 216.11 74.824 
0.323  Post 187.00 36.166 
Fat (g)  Pre 59.44 18.290 
0.500  Post 54.44 24.501 
Group B    
Energy (kcal) Pre 1696.25 258.578 
0.050  Post 2030.38 382.317 
Protein (g) Pre 72.25 16.968 
0.147  Post 83.38 17.541 
Carbohydrate (g) Pre 229.00 42.007 
0.281  Post 247.88 38.698 
Fat (g)  Pre 56.58 17.883 
0.041  Post 81.25 33.856 
4. Discussion 
There has been a paucity of studies investigating the effect of ginseng consumption on female 
testosterone and DHEA serum and saliva levels. To our knowledge, the results of this study seem 
to be novel. Nevertheless, the results support available scientific literature, suggesting that salivary 
testosterone and DHEA levels decrease with age as reported by the authors of [24,44]. Labrie et al. 
[24] also reported that the formation of DHEA and DHEAS declines with age, as do other 
researchers [41,43]. Furthermore, our results indicate that an ergogenic effect of ginseng intake on 
salivary DHEA occurred in women, and that it was greater in women aged 38–50 years than those 
aged 20–32 years.  
Subjects were responsible for daily ginseng consumption; consequently, the authors rely on the 
assumption that each subject complied. Furthermore, a review of scientific evidence has highlighted 
that the absorption and bioavailability of ginsenosides in humans are not yet clear [6,47]. 
Our study is a preliminary and exploratory trial, and we searched the literature and found that 
a 600 mg dose of ginseng root powder used by several studies and universally accepted does not 
produce side effects. We used 600 mg of Red Kooga Korean ginseng dried powder, which contains 
75 mg of standardized ginseng extract with a guaranteed ginsenoside content of 10%. Future trials 
will investigate the optimal dose condition of the dose–response relationship. One of the limitations 
of our study was that randomization was not properly implemented. Randomization was 
employed within each age group. However, following the completion of the study, we realized that 
only six volunteers took the placebo. Nevertheless, we completed the analysis and we did not 
observe any significance in all outcomes between the basal data of those taking the ginseng in both 
age groups and the data of post placebo intervention. This study identified the need for an 
adequately powered clinical trial to substantiate our results and establish the degradation pathways 
of ginsenosides in humans. Nevertheless, the results suggest that ginseng intake influences salivary 
androgenic hormones in female individuals. Saliva was the specimen collected as it was obtained 
by a non-invasive technique [48]. Moreover, multiple specimens could be obtained from the same 
individual allowing hormonal circadian rhythm identification; serum androgen concentration 
determination would have been invasive and impractical. In addition, several researchers have 
reported that saliva is a reliable diagnostic specimen [43,45,48–50]. 
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Salivary testosterone represents the concentration of bio-available testosterone. However, 
salivary DHEA represents bio-available DHEA and not DHEAS [51,52]. Levels of DHEA-S in saliva 
are compromised by the method of entry (ultrafiltration), as DHEA-S is a conjugated hormone. 
Unconjugated DHEA enters saliva simply by intracellular diffusion and represents the 
concentration of the unbound active DHEA in plasma [48,53]. Testosterone circulates in women 
plasma bound strongly to sex hormone binding globulin (SHBG) (66–74%) and 24–30% bound 
weakly to albumin with only about 1–3% being free in the blood [54,55]. Under certain conditions 
the bio-available testosterone dissociates from its carrier protein (mostly albumin) and becomes 
free. 
Steroid hormones in the periphery are believed to equilibrate rapidly between tissues and 
blood [56,57]. Total concentrations of testosterone in peripheral tissue and body fluids are mainly 
dependent upon the levels of binding proteins such as SHBG and albumin. These binding proteins 
can act as a reservoir for the steroid and protect it against extensive metabolism of active (free) 
steroids during passage of the blood through the liver [58]. Recently, salivary and serum 
testosterone levels were found to correlate significantly with calculated free testosterone in both 
controls and patients, whereas salivary and urine testosterone showed weaker correlations [59]. 
Other researchers reported that the correlation of serum and salivary concentrations taken before 
and after exercise was not as consistent as that observed during rest [60]. However, Lane and 
Hackney [61] reported a strong correlation observed between salivary and serum testosterone 
concentrations when exercising at both moderate and high intensities. 
Diet diaries were used to show that there was no significant difference between nutrient intake 
pre and post ginseng intervention when using a weighed intake or a diet diary [62]. It has been 
reported that carbohydrate, fat, and protein intake can influence androgen production [63,64]. 
Group A subjects’ intakes of energy, carbohydrate, fat, and protein were not significantly different 
pre and post ginseng supplementation. However, post ginseng supplementation energy and fat 
intake was slightly increased in group B subjects. These were analyzed using Windiet software that 
may have produced some errors as some foods consumed were often not listed and therefore 
substitute foods were used.  
The ELISA methods used to determine the levels of testosterone and DHEA were carefully 
developed and optimized by our in-house immunoassay laboratory [23,40,50]. These highly specific 
and sensitive assays are fully validated methods for the determination of salivary testosterone and 
DHEA. DHEAS, a conjugated hydrophilic steroid, enters saliva via ultrafiltration unlike DHEA, an 
unconjugated hydrophobic steroid, which enters saliva by intracellular diffusion [35]. The 
hydrophilic properties of DHEAS result in DHEAS being discarded in the aqueous solution during 
diethyl ether extraction [23]. Therefore, the concentration of DHEA in saliva truly represents the 
concentration of bio-available DHEA without DHEAS. Salivary analysis of DHEA has shown a 
significant positive correlation with plasma DHEA levels [65,66]. Salivary detection of DHEAS, on 
the other hand, has been shown to have limited useful indications of plasma DHEA levels due to 
low concentrations available in saliva, which can be readily affected by trace contamination [35]. 
Normal salivary testosterone and DHEA levels differ according to the individual laboratory. Our 
overall normal ranges for female salivary testosterone (18–69 years) were 58–246 pg/mL (a.m.) and 
32–166 pg/mL (p.m.), and those for DHEA were 115–674 pg/mL (a.m.) and 62–390 pg/mL (p.m.) 
[45,50]. A review of available literature highlights that contraceptive medication decreases bio-
available testosterone and DHEA [42]. However, none of our volunteers were taking oral 
contraceptives. Similarly, subjects agreed not to consume excessive amounts of alcohol during the 
study and alcohol consumption 24 hours prior to saliva collection was prohibited. Therefore, it was 
assumed that alcohol did not influence the results of the study.  
Steroid hormones demonstrate daily circadian rhythm as reported by many researchers 
[43,45,46]. These finding are supported by the fact that the secretion of androgens produced by the 
zona reticularis follows the actions of the adrocorticotrophic hormone (ACTH) on the adrenal 
gland. Mean salivary testosterone and DHEA concentrations in subjects aged 20–32 years pre and 
post ginseng intake showed a daily circadian rhythm as well as in subjects aged 38–50 years, 
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although at a reduced pattern (see Figures 1 and 2). Our study showed that mean salivary 
testosterone levels started to increase at 5 p.m. pre and post ginseng intake. This has been 
previously observed in some women due to increased physical activity, particularly in younger 
women [22,67,68], or presumably due to the decreased metabolism of testosterone caused by 
ginseng in older women and the low number of subjects in the study. However, salivary DHEA 
showed a typical daily circadian rhythm, which follows the ACTH secretion [22,31]. The basal mean 
± SD salivary testosterone concentration for women aged 20–32 years at 7 a.m. was 84.8 ± 
33.3pg/mL and, for women aged 32–50 years, it was 66.4 ± 27.6 pg/mL, which were expected and 
acceptable values. Furthermore, the mean ± SD basal DHEA levels at 7 a.m. were 2.06 ± 0.92 (group 
A) and 1.17 ± 0.45 (group B) [22,45,50]. 
Following ginseng intake, there was a marked increase in the mean daily salivary testosterone 
in group A. However, in group B subjects, there was a slight increase in mean daily salivary 
testosterone. In contrast, the mean daily salivary DHEA increased significantly following ginseng 
intake in groups A and B volunteers. To our knowledge, these results appear to be novel and it is 
worth conducting future studies using increased participation to determine if ginseng significantly 
increases testosterone and DHEA concentrations in women. If a ginseng supplement has the 
potential to increase salivary testosterone and DHEA, in particular, it could be beneficial to 
postmenopausal women and those with suspected insufficiency, as suggested by several 
researchers who reported that DHEA is beneficial when administered during menopause [24,33,69] 
as a substitute for androgen replacement therapy. Proposed mechanisms of action of ginsenosides 
could be due to several hypotheses, including an inhibitory activity of the enzymes that 
glucoronidate testosterone during metabolism and excretion in a way similar to the action of other 
compounds [70]. Moreover, the increase in DHEA levels could be attributed to the inhibition of the 
SULT2A1 enzyme that is responsible for the sulfonation of DHEA into DHEAS [23]. Furthermore, 
we can hypothesize that the erogenic effect of ginseng in women aged 38–50 years was greater 
possibly due to the delayed metabolism of ginsenosides in this group. However, the same cannot be 
said for testosterone. 
5. Conclusions 
It appears that a one-week ingestion of Korean ginseng slightly but significantly increased 
salivary testosterone and DHEA in younger women (aged 20–32 years) and salivary DHEA in older 
women (aged 38–50 years). However, it must be stressed that our results are preliminary and 
further properly controlled trials are justified. These data suggest a role for ginseng to play in 
modulating salivary androgen levels and that such an effect may be more evident in women above 
the age of 40 years where the levels of androgens, and particularly DHEA, start to decline. Such an 
erogenic effect could be beneficial to women when ginseng is administered to postmenopausal 
women in low doses. Future investigations are required to verify the type of ginsenosides that 
produces the erogenic effect in humans, identify the mechanism of action by which ginseng exerts 
its health benefits, and investigate gender, age, and BMI parameters.  
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